Trials / Unknown
UnknownNCT05947409
Single Arm Clinical Trial of Small Molecule Natural Flavonoid Compounds for Intervention in Neurodegenerative Diseases
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Mei Han · Academic / Other
- Sex
- All
- Age
- 25 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
1. Explore the effects of natural plant flavonoids on the positive intervention mechanism of neurotransmitter transmission physiological indicators changes (EEG) in the brain of the study subjects; 2. Investigate the effects of natural plant flavonoids in positively intervening clinical symptoms of the study subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SMARTO ONE | The SMARTO ONE® small molecule natural flavonoid compound product is provided by Beijing Jiafurui Biological Technology Co., Ltd. The intervention agent formula consists of extracts from Polygonum cuspidatum leaves, Fructus ligustri lucidi, Prunus mume, Semen ziziphi spinosae, celery, resistant maltodextrin, and steviol glycoside. Each package of the test product (3g) contains a total flavonoid content of 150mg. |
Timeline
- Start date
- 2023-08-15
- Primary completion
- 2024-06-15
- Completion
- 2024-12-31
- First posted
- 2023-07-17
- Last updated
- 2023-08-14
Source: ClinicalTrials.gov record NCT05947409. Inclusion in this directory is not an endorsement.